Abstract
We show that a combination of the immunosuppressive drugs, vitamin D3 and Dexamethasone, induced human and mouse naive CD4+ T cells to differentiate in vitro into regulatory T cells. In contrast to the previously described in vitro derived CD4+ T cells, these cells produced only interleukin (IL)-10, but no IL-5 and interferon (IFN)-γ, and furthermore retained strong proliferative capacity. The development of these IL-10–producing cells was enhanced by neutralization of the T helper type 1 (Th1)- and Th2–inducing cytokines IL-4, IL-12, and IFN-γ. These immunosuppressive drugs also induced the development of IL-10–producing T cells in the absence of antigen-presenting cells, with IL-10 acting as a positive autocrine factor for these T cells. Furthermore, nuclear factor (NF)-κB and activator protein (AP)-1 activities were inhibited in the IL-10–producing cells described here as well as key transcription factors involved in Th1 and Th2 subset differentiation. The regulatory function of these in vitro generated IL-10–producing T cells was demonstrated by their ability to prevent central nervous system inflammation, when targeted to the site of inflammation, and this function was shown to be IL-10 dependent. Generating homogeneous populations of IL-10–producing T cells in vitro will thus facilitate the use of regulatory T cells in immunotherapy.
Bibliography
Barrat, F. J., Cua, D. J., Boonstra, A., Richards, D. F., Crain, C., Savelkoul, H. F., de Waal-Malefyt, R., Coffman, R. L., Hawrylowicz, C. M., & OâGarra, A. (2002). In Vitro Generation of Interleukin 10âproducing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)â and Th2-inducing Cytokines. The Journal of Experimental Medicine, 195(5), 603â616.
Authors
10
- Franck J. Barrat (first)
- Daniel J. Cua (additional)
- André Boonstra (additional)
- David F. Richards (additional)
- Chad Crain (additional)
- Huub F. Savelkoul (additional)
- René de Waal-Malefyt (additional)
- Robert L. Coffman (additional)
- Catherine M. Hawrylowicz (additional)
- Anne O'Garra (additional)
References
77
Referenced
916
10.1016/S1074-7613(00)80533-6
/ Immunity. (1998)10.1146/annurev.iy.10.040192.002125
/ Annu. Rev. Immunol. (1992)10.1146/annurev.iy.12.040194.001303
/ Annu. Rev. Immunol. (1994)10.1084/jem.170.6.2081
/ J. Exp. Med. (1989)10.1016/S0952-7915(98)80084-8
/ Curr. Opin. Immunol. (1998)10.1084/jem.186.2.307
/ J. Exp. Med. (1997)10.1016/S0092-8674(00)80856-9
/ Cell. (2000)10.1146/annurev.med.48.1.341
/ Annu. Rev. Med. (1997)10.1084/jem.183.6.2669
/ J. Exp. Med. (1996)10.1016/S0167-5699(99)01559-5
/ Immunol. Today. (2000)10.1084/jem.188.2.287
/ J. Exp. Med. (1998)10.1016/S1074-7613(00)80404-5
/ Immunity. (1997)10.4049/jimmunol.151.3.1224
/ J. Immunol. (1993)10.1038/32588
/ Nature. (1998)10.1172/JCI2250
/ J. Clin. Invest. (1998)10.1084/jem.185.6.1089
/ J. Exp. Med. (1997)10.1084/jem.179.2.493
/ J. Exp. Med. (1994)10.1084/jem.192.9.1213
/ J. Exp. Med. (2000)10.1084/jem.193.2.233
/ J. Exp. Med. (2001)10.1146/annurev.immunol.19.1.683
/ Annu. Rev. Immunol. (2001)10.1038/39614
/ Nature. (1997)10.4049/jimmunol.164.10.5499
/ J. Immunol. (2000)10.4049/jimmunol.166.9.5530
/ J. Immunol. (2001)10.1073/pnas.93.15.7861
/ Proc. Natl. Acad. Sci. USA. (1996)10.1002/1521-4141(200002)30:2<498::AID-IMMU498>3.0.CO;2-Q
/ Eur. J. Immunol. (2000){'key': '2023072511303520300_BIB26', 'first-page': '1704S', 'volume': '125', 'year': '1995', 'journal-title': 'J. Nutr.'}
/ J. Nutr. (1995)10.1172/JCI1050
/ J. Clin. Invest. (1998)10.4049/jimmunol.164.9.4443
/ J. Immunol. (2000)10.1016/S0167-5699(97)01111-0
/ Immunol. Today. (1997)10.1016/S0092-8674(00)81177-0
/ Cell. (1998)10.4049/jimmunol.158.12.5589
/ J. Immunol. (1997)10.4049/jimmunol.161.10.5245
/ J. Immunol. (1998)10.1182/blood.V91.11.4255
/ Blood. (1998)10.1002/1521-4141(2000)30:8<2344::AID-IMMU2344>3.0.CO;2-7
/ Eur. J. Immunol. (2000)10.1002/1521-4141(200003)30:3<747::AID-IMMU747>3.0.CO;2-Y
/ Eur. J. Immunol. (2000)10.1073/pnas.94.25.13504
/ Proc. Natl. Acad. Sci. USA. (1997)10.4049/jimmunol.164.2.825
/ J. Immunol. (2000)10.1073/pnas.92.24.10990
/ Proc. Natl. Acad. Sci. USA. (1995)10.1128/MCB.15.10.5789
/ Mol. Cell. Biol. (1995)10.1126/science.2125367
/ Science. (1990)10.1006/clim.1999.4718
/ Clin. Immunol. (1999)10.1093/emboj/17.4.1006
/ EMBO J. (1998)10.1016/S0092-8674(00)80702-3
/ Cell. (2000)10.1002/j.1460-2075.1995.tb07100.x
/ EMBO J. (1995)10.1084/jem.189.6.1005
/ J. Exp. Med. (1999)10.1182/blood.V95.10.3162
/ Blood. (2000)10.1101/gad.14.14.1693
/ Genes Dev. (2000)10.1016/S0962-8924(00)01856-0
/ Trends Cell Biol. (2000)10.1073/pnas.96.7.3888
/ Proc. Natl. Acad. Sci. USA. (1999)10.1016/S1074-7613(00)80073-4
/ Immunity. (1999)10.1016/S0092-8674(00)80240-8
/ Cell. (1997)10.1016/S1074-7613(00)80671-8
/ Immunity. (1998)10.1084/jem.192.1.105
/ J. Exp. Med. (2000)10.1084/jem.187.2.177
/ J. Exp. Med. (1998)10.1084/jem.190.1.53
/ J. Exp. Med. (1999)10.1034/j.1600-065X.2000.917309.x
/ Immunol. Rev. (2000)10.1084/jem.190.7.995
/ J. Exp. Med. (1999)10.1677/joe.0.1320173
/ J. Endocrinol. (1992)10.1016/0167-5699(91)90158-P
/ Immunol. Today. (1991)10.1084/jem.169.2.431
/ J. Exp. Med. (1989)10.4049/jimmunol.167.4.1945
/ J. Immunol. (2001)10.1016/S1074-7613(00)80121-1
/ Immunity. (1999)10.1073/pnas.94.17.9279
/ Proc. Natl. Acad. Sci. USA. (1997)10.1146/annurev.iy.12.040194.005015
/ Annu. Rev. Immunol. (1994)10.1038/ni0901-816
/ Nat. Immunol. (2001)10.1016/S0092-8674(00)80412-2
/ Cell. (1997)10.1016/0952-7915(93)90063-X
/ Curr. Opin. Immunol. (1993)10.1111/j.1600-065X.1997.tb00969.x
/ Immunol. Rev. (1997)10.1126/science.7520605
/ Science. (1994)10.1084/jem.185.10.1769
/ J. Exp. Med. (1997)10.1006/jaut.1996.0045
/ J. Autoimmun. (1996)10.4049/jimmunol.155.3.1151
/ J. Immunol. (1995)10.1084/jem.188.10.1883
/ J. Exp. Med. (1998)10.4049/jimmunol.162.9.5317
/ J. Immunol. (1999)10.4049/jimmunol.147.9.2991
/ J. Immunol. (1991)10.4049/jimmunol.153.8.3514
/ J. Immunol. (1994)10.1002/1521-4141(200009)30:9<2639::AID-IMMU2639>3.0.CO;2-7
/ Eur. J. Immunol. (2000)
Dates
Type | When |
---|---|
Created | 23 years ago (July 26, 2002, 12:48 p.m.) |
Deposited | 2 years, 1 month ago (July 25, 2023, 7:31 a.m.) |
Indexed | 17 minutes ago (Aug. 25, 2025, 10:19 p.m.) |
Issued | 23 years, 5 months ago (March 4, 2002) |
Published | 23 years, 5 months ago (March 4, 2002) |
Published Online | 23 years, 5 months ago (March 4, 2002) |
Published Print | 23 years, 5 months ago (March 4, 2002) |
@article{Barrat_2002, title={In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines}, volume={195}, ISSN={0022-1007}, url={http://dx.doi.org/10.1084/jem.20011629}, DOI={10.1084/jem.20011629}, number={5}, journal={The Journal of Experimental Medicine}, publisher={Rockefeller University Press}, author={Barrat, Franck J. and Cua, Daniel J. and Boonstra, André and Richards, David F. and Crain, Chad and Savelkoul, Huub F. and de Waal-Malefyt, René and Coffman, Robert L. and Hawrylowicz, Catherine M. and O’Garra, Anne}, year={2002}, month=mar, pages={603–616} }